LEGALIZATION OF MEDICAL CANNABIS: FIVE CURRENT REFERENCE COUNTRIES
From the desk of Henry Levinski
National Director of Operations for Medcan Foundation, Inc.
Contact: + 1 817-528-2475 MB
Today at Medcan, we would like to give everyone a short summary of the importance of the work being carried out around the world within the niche of our company and the talents that are being generated in this emerging industry that we promote.
In every period in time, there has been a subject of controversy, difficult to accept, that it is incomprehensible to our sometimes innocent human ignorance. Without going too far, let’s remember when the idea that the Earth was round was chaotic and unacceptable to even think about it. In the same way today, accepting many aspects of life in our society generate the same debate, in which some defend their arguments and others have an invalid or invisible participation. The imminent importance of medicinal cannabis is the best example of this issue. From all corners of the world there is a new or old fight to educate people about the positive effects that this plant has against chronic diseases.
Medcan Foundation is forging the way in some US states and countries where there is already some hint of apprehension on the issue and even more in places that are structuring laws in favor of the medical cannabis industry.
In US states and territories such as Puerto Rico (which we already work hand in hand with), Texas, Mexico, Colombia, and more recently in South Africa, we are establishing ourselves with force.
We have been working very hard in Texas since the SB339 proposal by Sen. José Menéndez was presented in 2015, which enables the possession, use, cultivation, distribution, transportation and delivery of low-THC medicinal cannabis for epilepsy. We at Medcan have worked together with the Government to help Texas enter the list of the 28 States that approved the use of medical cannabis in the United States.
Recently there has been an amendment introduced to the Bill which seeks to replace the language of "prescription" for "recommend", create independent testing facilities, limit the application fee to just $5,000 and allow patients to cultivate at least 6 plants for personal use. These have been great advances for the industry in terms of legalization of the product, but not until May 2018 the State regulate and distribute the oil, supervised through the Department of Public Safety.
From the desk of Romina Porcara
Director of Operations for Medcan Foundation, Inc. Mexico
Contact: + 1 832 - 965-4350 MB
In Mexico, we are managing our first educational seminar which will be held on July 22 under the certification of the Autonomous University of Nuevo Leon (UANL) in the city of Monterrey Nuevo León.
Although a law has still not been established, there is an initiative with a draft decree whereby they reformed, added and repealed provisions of the general law of health and therefore amended article 195 of the Federal Penal Code. This initiative was presented by the federal executive and has entered into discussion since 2016 when it was sent to the Chamber of Senators.
However, we are already working in Mexico to promote this initiative and to teach doctors and the community in general that the cannabis industry will bring great benefits to the medical and scientific community.